Would you perform screening for pulmonary hypertension in a patient who has biopsy-proven Sjogren's but has a centromere antibody?
If symptoms include only sicca and Raynaud's with no respiratory symptoms, would you still be concerned enough with the centromere antibody to screen as if they're on the systemic sclerosis spectrum?
2 Answers
Mednet MemberInvited Expert
Rheumatology · Boston University School of Medicine
Answered on
Generally, the risk of pulmonary hypertension in Sjogren's is low - about 2% in a recent study using RHC for diagnosis (Coppi et al., PMID 40058609). There have been no studies linking Raynaud's to pulmonary hypertension risk in Sjogren's, although this is true in systemic sclerosis. So the real que...
Join for free or sign in to see the full answer
Mednet Member
Rheumatology · University of Chicago
Answered on
In the big scheme of things, an Echo and PFT are easy to do to catch PAH early. Screening is also recommended in the Sjogren's treatment consensus published in 2021 (Lee et al., PMID 33075377).
Join for free or sign in to see the full answer